We are live on ! Find out more
VMD icon

Viemed Healthcare

139 hedge funds and large institutions have $181M invested in Viemed Healthcare in 2025 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 52 increasing their positions, 44 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more call options, than puts

Call options by funds: $2K | Put options by funds: $1K

18% more repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 44

0% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 10

1% less funds holding

Funds holding: 141139 (-2)

1.7% less ownership

Funds ownership: 64.59%62.89% (-1.7%)

10% less capital invested

Capital invested by funds: $202M → $181M (-$20.8M)

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

Holders
139
Holders Change
-2
Holders Change %
-1.42%
% of All Funds
1.86%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.04%
New
10
Increased
52
Reduced
44
Closed
10
Calls
$2K
Puts
$1K
Net Calls
+$1K
Net Calls Change
-$15K
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$26.3M +$4.13M +525,799 +17%
Thrivent Financial for Lutherans
2
Thrivent Financial for Lutherans
Minnesota
$19.7M -$5.66M -720,693 -21%
FCM
3
Forager Capital Management
Alabama
$13.9M +$1.48M +188,304 +11%
Vanguard Group
4
Vanguard Group
Pennsylvania
$13M -$94.7K -12,061 -0.7%
WA
5
Wasatch Advisors
Utah
$9.51M -$173K -22,024 -2%
KLP
6
Kent Lake PR
Puerto Rico
$8.93M -$576K -73,420 -6%
NCM
7
Nantahala Capital Management
Connecticut
$6.79M -$21K -2,677 -0.3%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$5.7M +$146K +18,580 +2%
Goldman Sachs
9
Goldman Sachs
New York
$5.48M -$33.2K -4,231 -0.6%
State Street
10
State Street
Massachusetts
$4.54M -$52.5K -6,687 -1%
PAIM
11
Punch & Associates Investment Management
Minnesota
$4.22M -$2.09M -265,651 -31%
First Eagle Investment Management
12
First Eagle Investment Management
New York
$3.1M +$758K +96,520 +29%
TAM
13
Tocqueville Asset Management
New York
$3.04M
RA
14
Raffles Associates
New York
$2.93M
Renaissance Technologies
15
Renaissance Technologies
New York
$2.8M +$89.5K +11,400 +3%
BA
16
Bard Associates
Illinois
$2.55M +$762 +97 +0%
Dimensional Fund Advisors
17
Dimensional Fund Advisors
Texas
$2.22M -$9.55K -1,216 -0.4%
ACA
18
Apis Capital Advisors
New York
$2.21M +$192K +24,400 +9%
Northern Trust
19
Northern Trust
Illinois
$2.07M -$23.9K -3,042 -1%
RHJA
20
Rice Hall James & Associates
California
$1.89M +$3.26K +415 +0.2%
PAM
21
Panagora Asset Management
Massachusetts
$1.72M +$230K +29,252 +14%
Arrowstreet Capital
22
Arrowstreet Capital
Massachusetts
$1.7M +$319K +40,638 +21%
PM
23
Penbrook Management
New York
$1.5M -$57.2K -7,280 -3%
Russell Investments Group
24
Russell Investments Group
United Kingdom
$1.46M +$224K +28,584 +17%
LPL Financial
25
LPL Financial
California
$1.38M -$44.7K -5,699 -3%

VMD Hedge Fund Activity: Q1 2025 in Review

139 of the 7,457 institutional investors tracked by Wall St. Rank reported a position in Viemed Healthcare (VMD) for Q1 2025, worth a combined $181M — down 10% from $202M a quarter earlier.

Fund positioning in VMD was balanced in Q1 2025: 10 funds opened new positions, 10 closed out, 52 added to existing stakes and 44 trimmed.

The largest buyer was BlackRock, adding an estimated $4.13M. The largest seller was Thrivent Financial for Lutherans, cutting an estimated $5.66M.

  • 139 institutional investors held Viemed Healthcare (VMD) as of Q1 2025, down from 141 in Q4 2024.
  • Funds reported $181M of Viemed Healthcare stock for Q1 2025, down 10% quarter-over-quarter.
  • 10 funds opened new Viemed Healthcare positions in Q1 2025 and 10 closed out, a net change of 0 holders.
  • The largest Viemed Healthcare buyer in Q1 2025 was BlackRock, an estimated $4.13M added.
  • The largest Viemed Healthcare seller in Q1 2025 was Thrivent Financial for Lutherans, an estimated $5.66M sold.

Based on aggregated 13F filings for Q1 2025.